Patents by Inventor Shuhei Konagaya

Shuhei Konagaya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240124846
    Abstract: An object of the present invention is to provide an approach of removing non-endocrine unintended cells coexisting with insulin-secreting cells obtained by the differentiation. The present invention relates to a method for producing an insulin-producing cell population, comprising the step of treating an insulin-producing cell population obtained by the differentiation from pluripotent stem cells with a PLK inhibitor.
    Type: Application
    Filed: October 20, 2020
    Publication date: April 18, 2024
    Applicant: Orizuru Therapeutics, Inc.
    Inventors: Kensuke SAKUMA, Noriko YAMAZOE, Taro TOYODA, Shuhei KONAGAYA
  • Publication number: 20230399607
    Abstract: An object of the present invention is to provide a novel method for inducing the differentiation of pluripotent stem cells into an insulin-positive cell population. The present invention provides a method for producing an insulin-positive cell population, comprising differentiating a pancreatic progenitor cell population or a cell population at a later stage of differentiation in a medium containing a CDK8/19 inhibitor.
    Type: Application
    Filed: November 19, 2021
    Publication date: December 14, 2023
    Applicant: Orizuru Therapeutics, Inc.
    Inventors: Kensuke SAKUMA, Hirokazu MATSUMOTO, Taro TOYODA, Shuhei KONAGAYA
  • Publication number: 20230227787
    Abstract: An object of the present invention is to provide a novel approach capable of conveniently producing a large quantity of substantially uniform size cell aggregates. Provided is a method for producing cell aggregates using a cell culture bag, the cell culture bag having a lower face comprising a plurality of recesses, the method comprising the steps of: (1) adding cells and a medium to the cell culture bag, stirring the contents, and culturing the cells while applying a pressure to the cell culture bag; and (2) recovering the formed cell aggregates after the completion of culture.
    Type: Application
    Filed: May 27, 2021
    Publication date: July 20, 2023
    Applicants: Orizuru Therapeutics, Inc., Toyo Seikan Group Holdings, Ltd.
    Inventors: Junji YAMAURA, Ryo ITO, Taro TOYODA, Shuhei KONAGAYA, Ryo SUENAGA
  • Patent number: 11624049
    Abstract: Provided is a cell suspension culturing apparatus suitable for large-scale culture of cells, the cell culturing apparatus comprising a culture solution aspirator having a double-tube structure comprising an outer tube and an inner tube inserted in a lumen of the outer tube, and a suspension culture vessel, wherein in the culture solution aspirator, the outer tube comprises a filter through which a culture solution is passed, the inner tube comprises a suction port for the culture solution passed through the filter, and an air hole which communicates the lumen of the outer tube with the outside is disposed distally in a direction of insertion of the outer tube into the suspension culture vessel.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: April 11, 2023
    Assignee: Orizuru Therapeutics, Inc.
    Inventors: Junji Yamaura, Shinobu Kuwae, Taro Toyoda, Shuhei Konagaya
  • Publication number: 20220168357
    Abstract: An object of the present invention is to provide a novel method for producing a biological tissue-like structure comprising differentiated cells induced from pluripotent stem cells, and the present invention provides a method of forming a biological tissue-like structure together with host-derived blood vessels and connective tissue by transplanting a composition in which cells derived from pluripotent stem cells are disposed to be dispersed in a biocompatible material to induce the differentiation of the cells.
    Type: Application
    Filed: April 9, 2020
    Publication date: June 2, 2022
    Applicant: Orizuru Therapeutics, Inc.
    Inventors: Hideyuki HIYOSHI, Taisuke MOCHIDA, Noriko YAMAZOE, Junji YAMAURA, Taro TOYODA, Shuhei KONAGAYA
  • Publication number: 20210353686
    Abstract: The purpose of the present invention is to provide a novel method for making it possible to efficiently induce/produce endocrine cells from pluripotent stem cells. Insulin-producing cells including cells that are insulin-positive and NKX6.1-positive cells in a ratio of at least 30% and cells that are insulin-positive and NKX6.1-negative in a ratio of more than 15%.
    Type: Application
    Filed: September 18, 2019
    Publication date: November 18, 2021
    Applicants: Takeda Pharmaceutical Company Limited, Kyoto University
    Inventors: Ryo ITO, Noriko YAMAZOE, Hideyuki HIYOSHI, Taisuke MOCHIDA, Hikaru UENO, Kensuke SAKUMA, Junji YAMAURA, Hirokazu MATSUMOTO, Taro TOYODA, Shuhei KONAGAYA
  • Publication number: 20200392445
    Abstract: Provided is a cell suspension culturing apparatus suitable for large-scale culture of cells, the cell culturing apparatus comprising a culture solution aspirator having a double-tube structure comprising an outer tube and an inner tube inserted in a lumen of the outer tube, and a suspension culture vessel, wherein in the culture solution aspirator, the outer tube comprises a filter through which a culture solution is passed, the inner tube comprises a suction port for the culture solution passed through the filter, and an air hole which communicates the lumen of the outer tube with the outside is disposed distally in a direction of insertion of the outer tube into the suspension culture vessel.
    Type: Application
    Filed: December 21, 2018
    Publication date: December 17, 2020
    Applicants: Kyoto University, Takeda Phamaceutical Company Limited
    Inventors: Junji YAMAURA, Shinobu KUWAE, Taro TOYODA, Shuhei KONAGAYA
  • Publication number: 20160304839
    Abstract: Provided is a method for producing a pseudoislet, which method comprises: seeding 1,500 to 5,000 pluripotent stem cells in a cell culture well to prepare an aggregate of said pluripotent stem cells, said aggregate having a predetermined size; and culturing said aggregate in said cell culture well in a nonadherent state, to allow differentiation into cells including pancreatic islet progenitor cells and/or pancreatic islet cells.
    Type: Application
    Filed: April 15, 2016
    Publication date: October 20, 2016
    Inventors: Hiroo Iwata, Shuhei Konagaya, Kunio Hirano